Announcements Trials

Browse Landscape

Phase

Status

Completed 4 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 20 Burkitt Lymphoma 16 Lymphoma, Large B-Cell, Diffuse 11 Neuroblastoma 7 Lymphoma, Follicular 7 Lymphoma, B-Cell 7 Leukemia, Biphenotypic, Acute 7 Rhabdomyosarcoma 6 Lymphoma, T-Cell, Peripheral 6 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5 Sarcoma, Ewing 4 Lymphoma, T-Cell 4 Lymphoma 4 Retinoblastoma 3 Recurrence 3 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3 Osteosarcoma 3 Medulloblastoma 3 Lymphoma, Non-Hodgkin 3 Wilms Tumor 2 Sarcoma 2 Plasmablastic Lymphoma 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia, B-Cell 2 Leukemia 2 Hodgkin Disease 2 Ganglioneuroblastoma 2 Blastic Plasmacytoid Dendritic Cell Neoplasm 2 Stage I Mixed Cell Type Kidney Wilms Tumor 1 Rhabdomyosarcoma, Embryonal 1

Interventions

Vincristine 1 Endostatins 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Optic Nerve Glioma × Vincristine × Clear all

NCT05278715 2024-10-15

Modified CV Regimen in Optic Pathway Glioma

Beijing Sanbo Brain Hospital

Phase 2 Recruiting

Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡